CytoTools AG reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 0.00413 million compared to EUR 0.004277 million a year ago. Net loss was EUR 0.480053 million compared to EUR 0.601132 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.482 EUR | +12.09% | -10.74% | +8.07% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 2.68M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- CytoTools AG Reports Earnings Results for the Half Year Ended June 30, 2022